Home » Advanced Oncotherapy (AVO) » Brand CEO Alan Green discusses Defenx (DFX) & Advanced Oncotherapy (AVO) on Vox Markets podcast

Brand CEO Alan Green discusses Defenx (DFX) & Advanced Oncotherapy (AVO) on Vox Markets podcast

By in Advanced Oncotherapy (AVO), News and Views on .

Brand CEO Alan Green discusses Defenx (DFX) & Advanced Oncotherapy (AVO) with Justin Waite on the Vox Markets podcast. The interview is 36 minutes 20 seconds in.

Tags: , , , , , , , ,

Leave a comment

I would like to receive Brand Communications updates and news...
Free Stock Updates & News
I agree to have my personal information transfered to MailChimp ( more information )
Join over 3.000 visitors who are receiving our newsletter and learn how to optimize your blog for search engines, find free traffic, and monetize your website.
We hate spam. Your email address will not be sold or shared with anyone else.